Literature DB >> 19809871

RNA interference effectively degrades mRNA and inhibits protein expression of GBV-C E2 gene in Huh7 cells.

Ming-Mei Cao1, Gang Li, Hao Ren, Wei Pan, Ping Zhao, Zhong-Tian Qi.   

Abstract

The GB virus C/hepatitis G virus (GBV-C/HGV) is a Flaviviridae member that despite its nonpathogenicity, has become of great interest given that it could inhibit the replication of the human immunodeficiency virus (HIV). Therefore, a better knowledge of the viral protein E2 has become our aim. In this study, a GBV-C model cell system (HuhEG) which expressing a fusion protein of the GBV-C E2 protein and enhanced green fluorescent protein (EGFP) stably was established. And the expression of these proteins was silenced effectively by the two E2 gene-specific siRNAs and an EGFP gene-specific siRNA. This inhibition is sequence-specific and extensive (90%). This HuhEG/specific siRNAs system can provide an approach for investigating the association between GBV-C E2 and HIV replication, which may be of potential value in the development of novel prophylactic or therapeutic agents for HIV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19809871     DOI: 10.1007/s11262-009-0405-7

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  31 in total

1.  Inhibition of EGFP expression by siRNA in EGFP-stably expressing Huh-7 cells.

Authors:  Mingmei Cao; Hao Ren; Xin Pan; Wei Pan; Zhong-Tian Qi
Journal:  J Virol Methods       Date:  2004-08       Impact factor: 2.014

2.  Construction and identification of a single stranded cDNA clone containing full-length genome of hepatitis G virus.

Authors:  Z T Qi; H Ren; F L Zhu; L Shao; W Pan; W J Hu; J W He; X H Miao; P Du
Journal:  Ross Gastroenterol Zh       Date:  2001

3.  RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells.

Authors:  Joyce A Wilson; Sumedha Jayasena; Anastasia Khvorova; Sarah Sabatinos; Ian Gaël Rodrigue-Gervais; Sudha Arya; Farida Sarangi; Marees Harris-Brandts; Sylvie Beaulieu; Christopher D Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-19       Impact factor: 11.205

4.  Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons.

Authors:  J J Lefrère; F Roudot-Thoraval; L Morand-Joubert; J C Petit; J Lerable; M Thauvin; M Mariotti
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

5.  Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide.

Authors:  Elena Herrera; Maria J Gomara; Stefania Mazzini; Enzio Ragg; Isabel Haro
Journal:  J Phys Chem B       Date:  2009-05-21       Impact factor: 2.991

6.  Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C.

Authors:  Jeng-Fu Yang; Chia-Yen Dai; Wan-Long Chuang; Wen-Yi Lin; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wen-Yu Chang; Ming-Lung Yu
Journal:  Jpn J Infect Dis       Date:  2006-02       Impact factor: 1.362

7.  Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin.

Authors:  J Dubuisson; C M Rice
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Isolation of novel virus-like sequences associated with human hepatitis.

Authors:  J N Simons; T P Leary; G J Dawson; T J Pilot-Matias; A S Muerhoff; G G Schlauder; S M Desai; I K Mushahwar
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

Review 9.  GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals.

Authors:  Philip M Polgreen; Jinhua Xiang; Qing Chang; Jack T Stapleton
Journal:  Microbes Infect       Date:  2003-11       Impact factor: 2.700

10.  European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.

Authors:  J K Rockstroh; S Bhagani; Y Benhamou; R Bruno; S Mauss; L Peters; M Puoti; V Soriano; C Tural
Journal:  HIV Med       Date:  2008-02       Impact factor: 3.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.